Douglas P. Golwas
Chief Commercial Officer · Medline Inc.
- 2026
- Jun 17, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Douglas P. Golwas files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Hellman & Friedman Capital Partners X (Parallel), L.P. - $2.65B in MDLN purchases and sales in the last 12 months
- BCP 8 Holdings Mozart Manager L.L.C. - $2.35B in MDLN purchases and sales in the last 12 months
- BX Mozart ML-2 Holdco L.P. - $2.35B in MDLN purchases and sales in the last 12 months
- GIC Private Ltd - $1.81B in MDLN purchases and sales in the last 12 months
- Carlyle Group Inc. - $1.63B in MDLN purchases and sales in the last 12 months
- Carlyle Mozart Coinvestment Holdings, L.P. - $1.63B in MDLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Douglas P. Golwas?
Douglas P. Golwas is a corporate insider, tracked as Chief Commercial Officer of Medline Inc. (MDLN). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Douglas P. Golwas last file a Form 4?
The most recent primary Form 4 on record is dated 17 June 2026, one of 2 filings going back to 2026.
Has Douglas P. Golwas been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($3.68M) across all tracked filings.
